It's doubtful that we can predict the next meeting date based on the interval between just two past meetings.
Clinical trials are complex, and a variety of factors could affect the timing of future discussions.
The second round of stakeholder meetings was completed, which allows the GBA to gather further information for decision-making. The committee is now poised to commence the development of the study design.
These are substantial steps forward in a complex process.
Will be posting an opinion piece later why I think the trial is very beneficial from GBA point of view as well.
It's doubtful that we can predict the next meeting date based on...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.015(1.48%) |
Mkt cap ! $14.65M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 95.0¢ | $109.7K | 112.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23906 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 2292 | 2 |
View Market Depth
| Last trade - 15.57pm 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |